Navigation Links
The Quigley Corporation to Announce Second Quarter Results and Host Audio Web Cast
Date:7/30/2009

DOYLESTOWN, Pa., July 30 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY), www.quigleyco.com today announced it will issue its second quarter results before market open on Wednesday, August 5, 2009.

Ted Karkus, Chairman and CEO, will provide a Company overview including a review of recent activities and second quarter results on a conference call which will be web cast on The Quigley Corporation's web site, (www.quigleyco.com), at 10:00 AM (ET) that morning.

A replay of the conference call will be available for 30 days on the Company web site.

About The Quigley Corporation

The Quigley Corporation (Nasdaq: QGLY) (http://www.Quigleyco.com) is a diversified natural health medical science company. Its Cold Remedy segment is a leading marketer and manufacturer of the COLD-EEZE(R) family of lozenges, gums and sugar free tablets clinically proven to significantly reduce the severity and duration of the common cold. COLD-EEZE customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. The Quigley Corporation has several wholly owned subsidiaries including Quigley Manufacturing Inc., which consists of an FDA approved facility to manufacture COLD-EEZE(R) lozenges and fulfill other contract manufacturing opportunities, and Quigley Pharma Inc., (
'/>"/>

SOURCE The Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study
2. Ted Karkus Named CEO of The Quigley Corporation; Robert V. Cuddihy, Jr. Named Chief Operating Officer
3. Dr. Richard Rosenbloom Resumes Services To The Quigley Corporations Pharma Subsidiary
4. Ted Karkus Appointed Interim Chief Executive Officer Of The Quigley Corporation
5. Ted Karkus and Karkus Slate of Directors Prevail in Federal Court, Seated as Directors of The Quigley Corporation; Ted Karkus Elected Chairman of the Board
6. The Quigley Corporation Announces Final Voting Results for 2009 Annual Meeting of Shareholders; Judge Orders Incumbent Board to Remain In Place Until Further Hearing; Final Outcome of Director Election Remains Uncertain
7. Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation
8. Karkus Nominees Caution Quigley Shareholders Not to be Fooled by the Companys Latest Announcement
9. The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure
10. Judge Rejects Quigleys Claims - Karkus Director Candidates Prevail in Federal Court
11. Quigley Corporation Receives Support from Leading Independent Proxy Advisory Firms; RiskMetrics and Glass Lewis Reject Dissident Stockholder Ted Karkus, Citing Failure to Provide Detailed Business Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Resistance to artemisinin, the main drug to treat ... the Plasmodium falciparum ( P. falciparum ... likely caused by a genetic mutation in the ... therapyas opposed to a standard three-day coursehas proved ... to findings published today in the New ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July ... their preschooler shed excess pounds may want to team up ... joined them in a supervised behavioral modification program gained less ... child-only program (an average difference of about four pounds over ... pounds over two years, according to the study. "In ...
(Date:7/30/2014)... Hayward, CA (PRWEB) July 30, 2014 ... and accessories at the lowest prices on the internet ... Lightning Cables in two lengths and two colors. These ... performance standards. , The high quality SF Cable ... 8-pin connector with digital signal delivering faster charging and ...
(Date:7/30/2014)... 30, 2014 Imprivata ® ... management and secure communications solutions for the healthcare ... is the most widely selected single sign-on (SSO) ... Horizon electronic medical records (EMR) systems with a ... 11 percent in the last 12 months), according ...
(Date:7/30/2014)... -- Some obese people have a genetic mutation that ... brains when they see food, researchers report. Gaining ... of pleasure and gratification at the sight of high-calorie ... prevent overeating, the scientists suggested. More than one-third ... caused by a combination of overeating, a lack of ...
Breaking Medicine News(10 mins):Health News:Resistance to key malaria drug spreading at alarming rate in Southeast Asia 2Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 2Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 4Health News:SF Cable Delivers Certified Lightning Cable in Multiple Sizes and Colors 2Health News:Imprivata Achieves 51 Percent Single Sign-on Market Share Amongst U.S. Hospitals Using McKesson Paragon or Horizon EMR Systems, According to HIMSS Analytics 2Health News:Gene Mutation May Make Food More Tempting 2
... were being conducted towards pest control have lead to ... the University of California, have stated that the newly ... researchers who were initially looking for biological pest controls, ... from arthritis and other inflammatory diseases. It has been ...
... from the University of Georgia have conducted a new study ... in the body react to parasitic diseases that affect scores ... by scientists at the University of Georgia, that has been ... a peer-reviewed, open-access journal published by the Public Library of ...
... was described as being one of the crown jewels in NHS, ... NHS Trust acquired the// hospital on a lease in 2002. ... a great future in elective surgery. Ravenscourt Park, which had six ... million to help to cut waiting lists for operations. But there ...
... get a place in the Limca Book of Records earlier this ... bodies or individuals,// his coach said Tuesday. ,Biranchi Das, ... Rs.100 million promised to the boy he has not received even ... had advised that the boy should not run long distances. They ...
... 34 hospitals across the State according to new figures.// ... patients had their operations cancelled because the hospitals they were ... had no vacant beds. ,The State’s biggest hospital, ... year. Of these some 3,598 were said to have been ...
... Expanding waistlines has been a burgeoning healthcare problem, which has ... obesity rates, is also the increasing// numbers of myths doing ... subject of obesity has been conducted from time to time. ... has painted a dismal scenario of obesity rates by 2010, ...
Cached Medicine News:Health News:Pest Control research Leads to Pain Control Discovery 2Health News:Pest Control research Leads to Pain Control Discovery 3Health News:An All Important Breakthrough Reached In Understanding T cell response For Parasitic Diseases 2Health News:An All Important Breakthrough Reached In Understanding T cell response For Parasitic Diseases 3Health News:Cancellations of Operations touch 22,000 2
(Date:7/30/2014)... 30, 2014 In conjunction with DURECT Corporation,s ... results press release, you are invited to listen to ... the internet on Thursday, August 7, 2014 at 4:30 ... A live audio webcast of the presentation will be ... and clicking "Investor Relations."  If you are unable to ...
(Date:7/30/2014)... , July 30, 2014 PuraMed BioScience ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... M name along with the name,s red ... with the trademarked name MigraPure ®  going ... of PuraMed,s homeopathic, natural migraine pain reliever will ...
(Date:7/30/2014)... /PRNewswire-iReach/ -- Transluminal Technologies LLC, a ... announced today that they have received CE Mark ... Velox CD™ provides a safe and predictable means ... The single size velox CD™ is indicated for ... to 8F.  Velox CD™ utilizes patented ...
Breaking Medicine Technology:DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device 2
Herpes Simplex Virus 2 IgG ELISA....
Blunt tipped forceps with tungsten carbide treated jaws for enhanced gripping and removal of large sized foreign bodies....
Blunt tipped forceps with entire interior surface of tip serrated. For general purpose membrane grasping (coarse membranes)....
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Medicine Products: